期刊
THYROID
卷 28, 期 4, 页码 496-503出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/thy.2017.0473
关键词
lymph node; TNM staging; thyroid neoplasms; survival; metastasis
资金
- Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2017-707]
Background: Regional lymph node metastases (LNM) have prognostic significance in differentiated thyroid cancer (DTC). However, there was no distinction between N1a and N1b in the final staging classification in the eighth edition of the tumor-node-metastasis (TNM) staging system. This study aimed to evaluate the prognostic implication of N1b classification for predicting disease-specific survival (DSS) in DTC patients with stage I/II disease. Methods: A total of 3089 patients with stage I/II DTC who underwent thyroid surgery between 1996 and 2005 were included. DSS was evaluated according to N classification and number of LNM. A modification of the TNM was assessed that classified N1b cases in patients aged 55 years as stage IIB and the remaining cases as stage IIA. Results: The mean patient age was 45.6 years, and the median follow-up period was 10.0 years. In patients aged 55 years, patients with N1b had significantly poorer DSS compared to those with N0 (hazard ratio [HR]=11.0; p<0.001) and N1a (HR=4.2; p=0.013). The large-volume LNM group had significantly poorer DSS compared to the N0 (HR=10.1; p<0.001) and small-volume LNM (HR=3.9; p=0.019) groups. When patients were reclassified using the modified TNM staging system, DSS was significantly poorer in stage IIB patients than in stage IIA patients (HR=2.9; p=0.030). Conclusions: N1b classification has a significant prognostic implication in patients with stage I/II DTC, especially in older patients. Modified TNM staging employing N1b classification could be more useful for the prediction of DSS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据